ATE141271T1 - Aminosäure-derivate von chinolin und naphthyridin - Google Patents

Aminosäure-derivate von chinolin und naphthyridin

Info

Publication number
ATE141271T1
ATE141271T1 AT89117428T AT89117428T ATE141271T1 AT E141271 T1 ATE141271 T1 AT E141271T1 AT 89117428 T AT89117428 T AT 89117428T AT 89117428 T AT89117428 T AT 89117428T AT E141271 T1 ATE141271 T1 AT E141271T1
Authority
AT
Austria
Prior art keywords
amino acid
naphthyridine
quinoline
acid derivatives
amino
Prior art date
Application number
AT89117428T
Other languages
English (en)
Inventor
Daniel Tim-Wo Chu
Robert Hallas
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/400,111 external-priority patent/US5057520A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE141271T1 publication Critical patent/ATE141271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89117428T 1988-09-22 1989-09-21 Aminosäure-derivate von chinolin und naphthyridin ATE141271T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24799088A 1988-09-22 1988-09-22
US31326089A 1989-02-21 1989-02-21
US32840189A 1989-03-24 1989-03-24
US07/400,111 US5057520A (en) 1989-03-24 1989-09-01 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds

Publications (1)

Publication Number Publication Date
ATE141271T1 true ATE141271T1 (de) 1996-08-15

Family

ID=27500274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89117428T ATE141271T1 (de) 1988-09-22 1989-09-21 Aminosäure-derivate von chinolin und naphthyridin

Country Status (12)

Country Link
EP (1) EP0360258B1 (de)
JP (1) JP2938898B2 (de)
KR (1) KR100189474B1 (de)
AT (1) ATE141271T1 (de)
AU (1) AU616053B2 (de)
DE (1) DE68926941T2 (de)
DK (1) DK173511B1 (de)
ES (1) ES2092991T3 (de)
GR (1) GR3021342T3 (de)
IE (1) IE76284B1 (de)
IL (1) IL91648A (de)
NZ (1) NZ230727A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676445B1 (fr) * 1991-05-16 1995-02-03 Esteve Labor Dr Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments.
JP3113440B2 (ja) * 1992-03-25 2000-11-27 日本臓器製薬株式会社 ピリジニウム誘導体
TW252107B (de) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
JP3242792B2 (ja) * 1994-08-05 2001-12-25 日本臓器製薬株式会社 ナフチリジニウム誘導体
EP0806421A4 (de) * 1995-01-24 1998-04-15 Hokuriku Pharmaceutical Derivate der chinolincarbonsäure
EP1130021A3 (de) 2000-02-29 2004-03-03 Nippon Zoki Pharmaceutical Co., Ltd. Pyrrolopyridinium-Derivate
JP2004525109A (ja) 2001-02-15 2004-08-19 キング・ファーマシューティカルズ・インコーポレイティッド 安定化された甲状腺ホルモン医薬組成物、及びその製法
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US7589233B2 (en) 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
US8173840B2 (en) 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
KR101029764B1 (ko) * 2010-12-01 2011-04-19 라현수 축산분뇨, 하수슬러지를 토양미생물을 이용하여 발효시키는 장치 및 이를 이용한 발효퇴비 제조방법
CN103396396B (zh) * 2013-08-12 2015-09-09 西南大学 胺基烷酰克林沙星及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
US4479898A (en) * 1982-05-18 1984-10-30 Smithkline Beckman Corporation Oligopeptide prodrugs
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
US4604401A (en) * 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent

Also Published As

Publication number Publication date
EP0360258A2 (de) 1990-03-28
DK173511B1 (da) 2001-01-15
IL91648A (en) 1997-03-18
AU4172489A (en) 1990-04-26
NZ230727A (en) 1991-08-27
GR3021342T3 (en) 1997-01-31
JP2938898B2 (ja) 1999-08-25
DE68926941D1 (de) 1996-09-19
KR100189474B1 (ko) 1999-06-01
EP0360258A3 (de) 1991-06-05
JPH02142786A (ja) 1990-05-31
EP0360258B1 (de) 1996-08-14
IE76284B1 (en) 1997-10-08
DE68926941T2 (de) 1997-03-20
AU616053B2 (en) 1991-10-17
IE892964L (en) 1990-03-22
DK466889A (da) 1990-03-23
DK466889D0 (da) 1989-09-21
KR900004732A (ko) 1990-04-12
IL91648A0 (en) 1990-04-29
ES2092991T3 (es) 1996-12-16

Similar Documents

Publication Publication Date Title
NO175530C (no) Fremgangsmåte for fremstilling av 1H-imidazo(4,5-c)- kinoliner, og mellomprodukter derfor
DE68926941D1 (de) Aminosäure-Derivate von Chinolin und Naphthyridin
NO864518D0 (no) Fremgangsmaate for fremstilling av thiazolo(4,5-c)kinoliner
NO893305D0 (no) Heterocyklisk - substituerte kinolinkarboksylsyrer.
NO902179D0 (no) Fremgangsmaate for fremstilling av stimulerende aminosyre-antagonister.
ATE91625T1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
ES548285A0 (es) Procedimiento para la retirada de compuestos sulfurosos ga- seosos y anhidrido sulfuroso de los gases de combustion de un horno
ES2081797T3 (es) Aminoacidos y derivados peptidicos de 1,4-bis((aminoalquil e hidroxiaminoalquil)amino)-5,8-dihidroxiantraquinonas.
DK259486A (da) Fremgangsmaade til fremstilling af 7-aca-derivater
SE8902186L (sv) Nya polypeptider och deras anvaendning
EP0266942A3 (en) Ring laser gyroscope with geometrically induced bias
JPS6426596A (en) Homocyclostatin as hypotensive agent and cyclostatin-containing polypeptide
DE3677531D1 (de) Oxydation von kohle und schlacken.
KR880012585U (ko) 연소기기의 연소용 공기 공급상태 검출회로
KR870012652U (ko) 가스렌지용 안전밸브의 구동회로
KR870012651U (ko) 가스렌지용 안전밸브의 구동회로
KR890009316Y1 (en) Checked up search control circuit of the gas exhaust device
KR880009876U (ko) 링킹(ring king)머신의 구동장치
IT8847636A0 (it) Apparecchio per la rilevazione di emissioni laser
NO167653C (no) Fremgangsmaate for fremstilling av organiske forbindelser fra syntesegass.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee